Your unique download link appears right after you complete your purchase, and is also sent instantly to the email address you provided.
Table of Contents & Sample Chapter
This issue of Dermatologic Clinics, edited by Markham C. Luke, focuses on the pivotal role of the U.S. Food and Drug Administration (FDA) in dermatology. It explores how the FDA influences the development, approval, and regulation of dermatologic drugs, devices, and treatments, providing essential insights for clinicians, researchers, and healthcare professionals involved in dermatologic care and innovation.
Key Features
Focused coverage on the FDA’s role in dermatologic drug and device regulation.
Insights into approval processes, safety monitoring, and regulatory guidelines affecting dermatology.
Relevance for clinicians and researchers seeking to understand the impact of FDA policies on practice and innovation.
Evidence-based reviews highlighting regulatory considerations in dermatologic therapies.
E-book format for accessible, on-the-go reference and study.